<snip>3. No of Shares outstanding.: 110mm shares outstanding as of today. By the time the drug is approved, number of shares is most likely to go up to another 25% (to be safe). So for our calculations we will consider 110 * 1.25 = 137.5 mm<snip>
<snip>9.Now what is the chance of approval, taking a 50% chance of FDA approval will bring the value down to $4.215.
10. Approval will be at least 2 year away. For each year discount at least 20%. 4.215 – .843 = 3.372 3.372 – .6744 = 2.69
So we have calculated targeted value as $8.43. However we can say that now it is $2.5 stock<snipe>
Interesting read.....
But I am a new to these type stocks...
Looking at a chart I see a Golden Cross in our near future...
I caught it on the Thursday dip at 88 so I feel good...